On the basis of known complex transcriptional oncogenic changes observed in ATC[22,23,146] and the critical role of SRC-3 for transcriptional regulation, the expression of SRC-3 was examined during human thyroid cancer progression from normal, through DTC (FTC and PTC), to ATC[147]. The gene discussed is NCOA3; the disease is thyroid gland carcinoma.